Alfasigma USA Annual Revenue, Competitors, Number of Employees and Funding

Claim your profile

Overview

Location:
Covington, LA USA
Total Funding:N/A
Industry:Pharma
Founded:N/A
Lead Investor(s):N/A
Press
Claim your profile

Industry Ranking

State Ranking

Estimated Revenue & Financials

  • Alfasigma USA's estimated annual revenue is currently $23.3M per year.
  • Alfasigma USA's estimated revenue per employee is $201,000

Employee Data

  • Alfasigma USA has 116 Employees.
  • Alfasigma USA grew their employee count by 26% last year.
  • Alfasigma USA currently has 7 job openings.

Executive Contacts

NameTitleEmail
Jeffrey OliverDistrict ManagerEmail Available
Elaine Ludovico Director Commercial Finance - Commercial ControllerEmail Available
Suzanne MossSpecialty Territory ManagerEmail Available
Cary JohnsonTerritory ManagerEmail Available
Jason KimballRegional Sales Director - West UsEmail Available
Ryan WittmanSales Territory ManagerEmail Available
Madhusudan VudathalaVice President,head Of Manufacturing OperationsEmail Available
Jaime CapizziDistrict Manager, Kansas City DistrictEmail Available
Mark JohnstonNational Trade Account ManagerEmail Available
Billy RheamsDistrict Sales Manager

Pamlab, formerly part of Nestle Health Sciences, is now Alfasigma USA. Alfasigma USA, Inc. distributes a portfolio of prescription nutritional products to help individuals who are suffering from GI disorders (VSL#3®), major depressive disorder (Deplin®), diabetic peripheral neuropathy (Metanx®), and mild cognitive impairment (CerefolinNAC®). Through the company's commitment to improving patients health and quality of life, Alfasigma USA, Inc. strives to provide innovative solutions that respond to the needs of a changing society. Alfasigma USA has corporate headquarters in Covington, LA and a newly opened commercial hub in Bedminster, NJ. Discover Alfasigma USA at http://www.alfasigmausa.com.

keywords:N/A

116

Number of Employees

$23.3M

Revenue (est)

7

Current Jobs

26%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Alfasigma USA
$23.3M11626%N/A
S-Clinica
$8.2M41N/AN/A
Southern Script...
$17.9M8944%N/A
Missing a competitor? Contribute!?
Submit

Alfasigma USA News

09/03/2019 - Alfasigma USA Announces ZELNORM™ (tegaserod) Now ...

Alfasigma USA, Inc. today announced that ZELNORM™ (tegaserod) is now available in the United States as a prescription pharmaceutical ...

09/08/2019 - Alfasigma brings Zelnorm back to US market

The US subsidiary of Italian drugmaker Alfasigma yesterday announced that Zelnorm (tegaserod) is now available in the USA as a prescription ...

09/03/2019 - Global Irritable Bowel Syndrome (IBS) Market Size 2019 ...

... market are Allergan Plc (Ireland), Sucampo Pharmaceuticals (U.S.), ... Sebela Pharmaceuticals (Ireland), Probi (Sweden), Alfasigma USA, ...